Neurology® Podcast

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 517:31:14
  • More information

Informações:

Synopsis

The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. Regular features also include the Lesson of the Week, Delayed Recall, Whats Trending, and selected content from Neurology® Today. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed Recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Tuesday.

Episodes

  • Teratogenesis and Neurodevelopment on Antiseizure Medication: A Practice Guideline

    16/05/2024 Duration: 16min

    Dr. Howard Goodkin talks with Dr. Alison M. Pack about the new updated guidelines piece on the conclusions and recommendations regarding the effects of antiseizure medications and folic acid supplementation on the prevalence of MCMs, adverse perinatal outcomes, and neurodevelopmental outcomes in children born to PWECP. Read the related article in Neurology. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

  • Neurologic Diagnoses after COVID-19 or Influenza Hospitalization

    13/05/2024 Duration: 20min

    Dr. Derek Stitt talks with Dr. Adam de Havenon about the burden of neurologic health care and incident neurologic diagnoses in the year after COVID-19 vs influenza. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

  • Long-Term Follow-Up of the LEAP Study

    09/05/2024 Duration: 11min

    Dr. Vikram Karnik talks with Dr. Rob de Bie about early vs. delayed start of Levodopa in early Parkinson disease, and what it means for clinical practice. Read the related article in International Parkinson and Movement Disorder Society. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.  

  • Herpes Simplex Virus Encephalitis

    06/05/2024 Duration: 13min

    Dr. Justin Abbatemarco talks with Dr. Alice Tang about the association between immune status and herpes simplex virus encephalitis. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

  • Unrecognized Focal Non-Motor Seizures in Adolescents

    02/05/2024 Duration: 17min

    Dr. Halley Alexander talks with Drs. Jacqueline French and Nora Jandhyala about investigating ED recognition of motor vs. non-motor seizures and its effect on the management and treatment of focal epilepsy in adolescents. Read the related article in Neurology. Disclosures can be found at Neurology.org.

  • May 2024 Neurology Recall: Topics in Neuro-Oncology

    01/05/2024 Duration: 01h09min

    The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa. Podcast Links: MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients   New Treatment for IDH mt Gliomas  Study of Vaccine-Based Therapy for GBM Brain Tumor Programs in Asia and Africa  Article Links: https://doi.org/10.1212/WNL.0000000000207670  https://www.nejm.org/doi/full/10.1056/NEJMoa2304194 https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847 https://doi.org/10.1016/j.wneu.2023.04.067 Dis

  • sNfL and Radiologic Disease Activity in Patients With MS

    29/04/2024 Duration: 18min

    Dr. Justin Abbatemarco talks with Dr. Bob Fox about the relationship between serum neurofilament light chain (sNfL) levels and radiologic multiple sclerosis disease activity. Read the related article in Neurology. Disclosures can be found at Neurology.org.

  • Clinical Characteristics and Long-Term Outcomes of Late-Onset MS

    25/04/2024 Duration: 19min

    Dr. Justin Abbatemarco talks with Dr. Ellen Iacobaeus about patient characteristics, disease-modifying therapy, and disability progression in Swedish patients with late-onset MS and adult-onset MS over 2 decades. Read the related article in Neurology.   Disclosures can be found at Neurology.org.  

  • Skin Biopsy Detection of Phosphorylated α-Synuclein

    22/04/2024 Duration: 22min

    Dr. Jeff Ratliff talks with Dr. Chris Gibbons about the use of skin biopsies to detect phosphorylated α-synuclein in individuals with synucleinopathies such as Parkinson disease, multiple system atrophy, dementia with Lewy bodies, and pure autonomic failure. Read the related article in JAMA.  Disclosures can be found at Neurology.org.

  • Physicians as Patients Series - Arteriovenous Malformation Part 2

    18/04/2024 Duration: 19min

    As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Amy Hessler about her experience with a ruptured arteriovenous malformation as a 2nd-year neurology resident.  Disclosures can be found at Neurology.org.

  • Physicians as Patients Series - Arteriovenous Malformation Part 1

    15/04/2024 Duration: 15min

    As part of our "Physician as Patient" series, Dr. Andy Southerland talks with Dr. Joe Sirven about his experience with a ruptured arteriovenous malformation. If you're attending the AAN Annual Meeting in Denver, you can catch this conversation and more in a live Q&A session on April 16th at 2:30 pm MT at the publication stage. Disclosures can be found at Neurology.org.

  • Educating Child Neurology Residents About PNES

    11/04/2024 Duration: 18min

    Dr. Jeff Ratliff talks with Drs. Dara V. F. Albert and Afsaneh Talai about understanding the gaps in resident education on psychogenic nonepileptic seizures. Read the related article in Neurology: Education.  Disclosures can be found at Neurology.org.

  • Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

    08/04/2024 Duration: 17min

    Dr. Kait Nevel talks with Dr. Elizabeth Gerstner about the use of CAR-T cells in the treatment of glioblastoma.  Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org.  

  • Impact of Immune Checkpoint Inhibitors

    04/04/2024 Duration: 12min

    Dr. Justin Abbatemarco talks with Dr. Géraldine Androdias about the impact of immune checkpoint inhibitors on the course of multiple sclerosis. Read the related article in Neurology: Neuroimmunology and Neuroinflammation.  Disclosures can be found at Neurology.org.

  • Space Headaches Experienced by Astronauts

    01/04/2024 Duration: 19min

    Dr. Jessica Ailani talks with Dr. Willebrordus Petrus Johannes Van Oosterhout about the occurrence, characteristics, and evolution of space headaches during long-duration flights. Read the related article in Neurology.  Disclosures can be found at Neurology.org.

  • April 2024 Neurology Recall: FND Awareness Month

    01/04/2024 Duration: 01h14min

    The April 2024 replay of past episodes showcases four incredible interviews on functional neurologic disorders. The episode begins with the 3-part FND roundtable discussion with Prof Jon Stone discussing various topics in FND with Drs. Selma Aybek, David Perez, and Sarah Lidstone. In the first discussion they touch on FND diagnosis and exploring new phenotypes. The second discussion is on how and why FND and the third discussion is on treatments for FND. The episode concludes with Dr. Halley Alexander’s conversation with Dr. Genna Waldman about reviewing psychogenic non-epileptic events. Related Links: An Updated Round Table Discussion on FND: Diagnosis of FND and New Phenotypes An Updated Round Table Discussion on FND: How and Why Does FND Occur? An Updated Round Table Discussion on FND: Sharing a Diagnosis and Treatment Reviewing Psychogenic Non-Epileptic Events Disclosures can be found at Neurology.org.

  • Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

    28/03/2024 Duration: 24min

    Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation.  Disclosures can be found at Neurology.org.

  • A Discussion with Dr. Avindra Nath: Ted Burns Humanism Award Winner

    25/03/2024 Duration: 19min

    Dr. Jeff Ratliff speaks with Dr. Avindra Nath, the recipient of the 2024 American Brain Foundation Ted Burns Humanism in Neurology Award. Read more about the Ted Burns Humanism in Neurology Award. Disclosures can be found at Neurology.org.

  • Effectiveness of Seizure Dogs

    21/03/2024 Duration: 15min

    Dr. Halley Alexander talks with Dr. Valérie van Hezik-Wester about whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog. Read the related article in Neurology.  Disclosures can be found at Neurology.org. 

  • Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Anti-Seizure Medication

    18/03/2024 Duration: 21min

    Dr. Halley Alexander talks with Dr. Genevieve Rayner and Eliza Honybun about the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes.  Disclosures can be found at Neurology.org.

page 4 from 59